In a significant ruling, the Bombay High Court has said that it would be the responsibility of the Centre in case any faulty ventilators supplied by a Gujarat company through the PM CARES Fund cause deaths of COVID-19 patients.
In its verdict on Wednesday, a division bench, comprising Justice Ravindra Ghuge and Justice BU Debadwar, said that they would "not permit experimentation of ventilators which have undergone major repairs in treating the patients, since this would be causing a risk/health hazard to the patients, and unfortunately, the use of such ventilators may cause loss of life, which must be averted."
After a submission by the additional solicitor-general of India Anil Singh, that a team of expert doctors from New Delhi—one each from Ram Manohar Lohia Hospital and Safdarjung Hospital— would visit the Government Medical College & Hospital, Aurangabad (GMCH) on Thursday to inspect the defective ventilators, the court has posted the matter for further hearing on 7th June.
The matter pertains to 150 ventilators provided to the GMCH in April under the PM CARES Fund which were supplied by Rajkot-based Jyoti CNC, of which around 133 were found to be defective or malfunctional. (IANS Report-May 18).
A GMCH committee had submitted a report on the ventilators which suffered continuous breakdowns even after repairs, and hence the machines were not being used as a precautionary measure with the Maharashtra Congress spokesperson Sachin Sawant raising the issue in a big way.
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
Corona Virus (COVID-19) Latest Updates
09 June 2021
India records over 92,000 Covid cases, 2,219 deaths in 24 hours
India on Wednesday logged 92,596 new Covid infections in 24 hours, less than one lakh cases for the second straight day and 6,098 cases more...
After Pfizer, Moderna, now SII seeks indemnity from liability: Sources
03 June 2021
Pune-based Serum Institute of India (SII), which manufactures Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources.
This comes as the Centre is...
'Arbitrary, Irrational': SC on Centre's Vaccine Policy for 18-44 Yrs
02 June 2021
The Supreme Court on Wednesday made scathing remarks on Centre's vaccination policy against COVID-19, terming the replacement of free vaccination in the first two phases with paid vaccination for persons between 18-44 years as prima...
Supreme Court Asks Union Govt To Furnish All Data on Purchase of COVID-19 Vaccines
Moneylife Digital Team
02 June 2021
The Supreme Court on Wednesday asked the Indian government to furnish all data oon its purchase history of three vaccines for coronavirus (COVID-19) three vaccines Covaxin, Covishield and Sputnik V.
In its order, a bench...